Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain
about
Virus maturation as a new HIV-1 therapeutic targetSultam Thiourea Inhibition of West Nile VirusHigh-throughput profiling of point mutations across the HIV-1 genome.Novel approaches to inhibiting HIV-1 replication.Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid.Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Analysis of the N-terminal region of the murine leukemia virus nucleocapsid proteinSlower uncoating is associated with impaired replicative capability of simian-tropic HIV-1Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domainSecond-site compensatory mutations of HIV-1 capsid mutations.Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein.A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid proteinIncorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particlesThe interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability.Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly.Characterization of the in vitro HIV-1 capsid assembly pathway.Analysis of human immunodeficiency virus matrix domain replacements.HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.New approaches for antiviral targeting of HIV assembly.Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid.Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA.A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores.Isolated HIV-1 core is active for reverse transcription.RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and releaseForced Complementation between Subgenomic RNAs: Does Human Immunodeficiency Type 1 Virus Reverse Transcription Occur in Viral Core, Cytoplasm, or Early Endosome?
P2860
Q24642446-90025A44-703E-48C6-A544-A5A8373A74EEQ27480794-E0B5916D-719F-4B77-BB6B-881599521D83Q30369959-6322F2F9-D32A-4E4B-A6EB-FB20E92AB70BQ33624690-A289B87C-644F-41BE-8322-BC36DC8EF21BQ33774977-D52C5641-C637-4B25-91A9-C2A78A951482Q33826918-072C5E5B-C1A3-4E3A-B217-9E8B59FCE77BQ34552402-BD56F8CA-1BB1-40EF-A05A-A17B6C866D0FQ34965309-0D577A8C-ECAE-4127-B8A4-C86208C7224EQ34989840-C729B554-0D51-4FBB-A57E-6925B25E5F66Q35076692-B3A50EC2-584B-48E8-92A3-B224E49B18F1Q35477673-20CE2DFE-8C84-4802-B00F-7B98A1FB063EQ35750243-413979EF-47C6-48AA-81B9-A8263FCD8B58Q35857486-0BEC31B3-E40D-4CB2-8025-1AE779C2DA58Q36614059-BAF38C01-D4C3-4C68-84B9-107CE827A4F1Q36950909-49DCE40D-7248-4EDF-A479-C045018E8A09Q37155570-3B83B8A3-7C57-4EB4-99E9-6AACAA67EB73Q37255552-183CECEB-04A9-4040-BCEE-B0E1B1CD3871Q37705207-0432F944-8B65-4EC7-B5D0-1A545CEBF0A4Q37901613-EC5A0CE2-0163-4E52-941F-9249A9B52024Q38716274-C571CB92-80DF-4F2C-A03C-130DE9A451E7Q39065469-A84FAB16-C8BB-4D75-8D4B-CFFB0E32D107Q39180622-F8BB3E03-6FE2-4E92-A5C7-07F0783A43DEQ39641782-940659F3-FD10-40B0-840A-84BFBFF62899Q39795056-48FC036E-696E-4700-B08C-2F222CA75188Q40174170-A261CCE5-3134-48A6-9E22-E682EDFDBDEAQ40176627-0904F00D-9186-47AF-AEC7-3638B0FC1F53Q40311599-D285EFF2-98C5-47A1-AC9B-ED25BE6D1A93Q41956340-02897E9B-26BD-4BAE-9862-4FD07E3414FBQ42209615-3D0F6931-3967-4434-8910-D906CEA4F03BQ56988804-72F10CA0-BF5D-4EA8-AD12-9162DEB404C5
P2860
Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Virus particle core defects ca ...... virus capsid N-terminal domain
@ast
Virus particle core defects ca ...... virus capsid N-terminal domain
@en
type
label
Virus particle core defects ca ...... virus capsid N-terminal domain
@ast
Virus particle core defects ca ...... virus capsid N-terminal domain
@en
prefLabel
Virus particle core defects ca ...... virus capsid N-terminal domain
@ast
Virus particle core defects ca ...... virus capsid N-terminal domain
@en
P2093
P2860
P1433
P1476
Virus particle core defects ca ...... virus capsid N-terminal domain
@en
P2093
Brian Arvidson
Doug Huseby
Eric Barklis
Isabel Scholz
P2860
P304
P356
10.1128/JVI.79.3.1470-1479.2005
P577
2005-02-01T00:00:00Z